“The Therapeutic Goods Administration (TGA) does not consider the presence of the SV40 promoter to be a safety concern either before or after the product is subjected to DNA digestion and purification.”
And “The TGA is unable to provide the sequences requested as they are commercial in confidence.” (See comments)”
••••••••••••••••••••••••••••••
Turns out the previous answers like this answer were no answers by claiming commercial in confidence.
In light of the evidence released last week via FOI where the TGA admitted that:
“foreign DNA can integrate into chromosomal DNA in the absence of an integrase in mammalian cells. This comes from the DNA damage/repair literature where breaks in DNA are repaired through processes called non-homologous end joining or homologous recombination. Exogenous DNA can potentially be incorporated using these processes.”
It is clear the TGA have been caught lying again. The SV40 is a promoter that can initiate DNA replication, so the SV40 promoter has to be a safety concern.
Given no carcinogenic testing was carried out then the TGA can’t rule out anything.
Furthermore the genetic sequence of the plasmids should not be commercial in confidence.
Luckily the sequence has already been released via scientists in Canada.
The TGA are again protecting big pharma instead of protecting the people.
Senator RENNICK: I can do that. That’s fine. Can the TGA rule out categorically that the SV40 primer wasn’t used in the plasmids that were used under process 2? As you know, there was process 1 and process 2, whereby plasmids were used to make commercial-grade batches. Can you please provide what the sequence of those plasmids used in process 2 were, please?
Dr Kerr : I can respond to that. We answered the question about the SV40 codon numerous times before, including in SQ23-002051, SQ23-002232 and SQ23-002232.
Senator RENNICK: That’s fine, but I haven’t asked for the entire sequence. So it’s not just the primer but the entire nucleotide sequence of the plasmids that were used in process 2. Would you be able to provide them on notice?
Dr Kerr : The sequence of the plasmids are not different between process 1 and process 2. We’ve actually—
Senator RENNICK: Well—plasmids that weren’t used in process 1.
Mr Comley : Chair, could we please allow the witnesses to finish the response?
Senator RENNICK: I have been. I am.
CHAIR: Dr Kerr.
Dr Kerr : We have answered that question before, in SQ24-000229 and SQ24-001492.
CHAIR: Senator, I’m about to pass the call.
Senator RENNICK: Can you take it on notice, please? Can I get the entire sequence of the plasmids that were used in process 2, please.
Dr Kerr : We can take that on notice.
Senator RENNICK: Thank you.
Prof. Lawler : I would highlight that we may not be in the position to provide entire sequences of substances, but we will take that on notice.
Senator RENNICK: But, given this is related to the safety of the vaccine, I would have thought it was very important that this question was answered.
Prof. Lawler : We’ll take the question on notice.
